SCHEMBL1418260

SCHEMBL1418260

CCCCOC(=O)CN(C)CC=CC(=O)Nc1cc2c(Nc3cccc(Br)c3)ncnc2cc1OC

nearest known ligand 0.60

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 20/20 0.60
▸ ERBB2 P04626 9/20 0.60
▸ JAK3 P52333 1/20 0.53
▸ ERBB4 Q15303 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1418259 1.00 EGFR (0.60) EGFRERBB2JAK3ERBB4
SCHEMBL1418839 0.97 EGFR (0.59) EGFRERBB2
SCHEMBL1418841 0.97 EGFR (0.59) EGFRERBB2
SCHEMBL1418183 0.96 EGFR (0.62) EGFRERBB2JAK3ERBB4
SCHEMBL1418182 0.96 EGFR (0.62) EGFRERBB2JAK3ERBB4
SCHEMBL1418061 0.94 EGFR (0.62) EGFRERBB2JAK3ERBB4
SCHEMBL1418063 0.94 EGFR (0.62) EGFRERBB2JAK3ERBB4
SCHEMBL1418997 0.93 EGFR (0.65) EGFRERBB2JAK3ERBB4
SCHEMBL1418995 0.93 EGFR (0.65) EGFRERBB2JAK3ERBB4
SCHEMBL1417867 0.90 EGFR (0.60) EGFRERBB2JAK3ERBB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2298746-A1 4-amino- quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2011-03-23 — — EP disclosed
Send feedback